VTCN1 and cervical carcinoma: Experimental silencing of VTCN1 in cervical cancer models resulted in increased tumor suppressor retinoblastoma protein mRNA levels and decreased expression of the HPV E7 oncoprotein, implicating B7-H4 in the E7/Rb regulatory axis [119].